BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $26,425,000 | -41.3% | 413,665 | -1.7% | 0.01% | -31.2% |
| Q4 2021 | $45,055,000 | -11.0% | 420,646 | -14.6% | 0.02% | -15.8% |
| Q3 2021 | $50,612,000 | +12.6% | 492,287 | -3.7% | 0.02% | +11.8% |
| Q2 2021 | $44,949,000 | -9.4% | 511,021 | +0.1% | 0.02% | -15.0% |
| Q1 2021 | $49,639,000 | -13.3% | 510,533 | -0.0% | 0.02% | -16.7% |
| Q4 2020 | $57,278,000 | +20.9% | 510,716 | -0.1% | 0.02% | +4.3% |
| Q3 2020 | $47,378,000 | +52.1% | 511,091 | +28.7% | 0.02% | +43.8% |
| Q2 2020 | $31,146,000 | +432.1% | 397,024 | +296.7% | 0.02% | +300.0% |
| Q1 2020 | $5,853,000 | -26.8% | 100,083 | -50.0% | 0.00% | 0.0% |
| Q1 2017 | $7,998,000 | +42.6% | 200,000 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $5,610,000 | – | 200,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |